Higher addiction medication dose tested to keep patients in treatment
NCT ID NCT06316830
Summary
This study is testing if a higher daily dose (24 mg) of the addiction medication buprenorphine helps people with fentanyl addiction stay in treatment longer than the standard dose (16 mg). Researchers will enroll 250 adults in Rhode Island who are starting or continuing treatment for opioid addiction. The main goal is to see if the higher dose improves how long people stay in treatment and reduces cravings and opioid use over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Brown University
RECRUITINGProvidence, Rhode Island, 02912, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.